The 8 analysts offering 12-month price forecasts for Zealand Pharma A/S have a median target of 42.33, with a high estimate of 58.00 and a low estimate of 33.11. The median estimate represents a +8.64% increase from the last price of 38.96.
The current consensus among 8 polled investment analysts is to Buy stock in Zealand Pharma A/S. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.25
Reporting Date Aug 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.